Biomechanical Understanding of Ascending Thoracic Aortic Aneurysms
胸主动脉瘤的生物力学理解
基本信息
- 批准号:8888208
- 负责人:
- 金额:$ 38.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAneurysmAortaAortic AneurysmBicuspidBiomechanicsCaliberCardiacCardiovascular systemCause of DeathClinicalClinical TrialsComputer SimulationConduct Clinical TrialsConnective TissueCoupledDataDecision MakingDevelopmentDissectionEmergency SituationEventFailureFoundationsFutureGeometryGoalsGoldGrowthGuidelinesHealthHospital MortalityHospitalsImaging TechniquesKnowledgeLiquid substanceLiteratureMagnetic Resonance ImagingMeasuresMechanicsMethodologyModelingMorphologyMotivationOperative Surgical ProceduresOutcomePathologyPatientsPhasePropertyProspective StudiesResidual stateResolutionRiskRisk FactorsRuptureSpecific qualifier valueSpecimenStressStructureSwellingSymptomsTestingThickThoracic Aortic AneurysmThoracic aortaTimeUncertaintybaseclinical applicationclinical decision-makingclinical riskcompare effectivenesshigh riskimprovedin vivoin vivo Modelinnovationmechanical behaviormortalitynon-invasive imagingpressureprospectiveregional differencerepairedshear stresssimulation
项目摘要
DESCRIPTION (provided by applicant): Dissection and/or rupture of ascending thoracic aortic aneurysms (aTAA) are catastrophic emergencies with 40% pre-hospital mortality, and operative mortality as high as 25%. Clinical guidelines recommend elective surgical repair based primarily on aTAA size, as well as growth, symptoms, and bicuspid or connective tissue pathologies. However, significant proportion of type A dissection patients presented with aortas under specified size limits for repair. Our long-term goal is to modernize clinical aTAA decision-making using patient-specific biomechanics, fluid dynamics, and clinical profiles to predict rupture/dissection and risk-stratify patients for earlier surgical repair. The rationale is that aTA rupture/dissection is a mechanical failure occurring when wall stress exceeds wall strength. Guidelines use diameter as a surrogate for wall stress based on LaPlace's Law. We hypothesize that fluid structure interaction (FSI) analyses of aTAA wall stress is a better predictor of true wall stress and therefore better predict adverse clinical events than diameter. True wall stress, unfortunately, cannot be measured directly in vivo but requires ex vivo aTAA specimens, where patient-specific 3D zero- pressure geometry, wall thickness, residual stress, and material properties can be measured with very high resolution. Prior aTAA computational models have made numerous assumptions using generalized wall thickness, literature-based material properties, and often ignored zero-stress geometry-all of which substantially change simulation results. The Achilles heel of aTAA models to date is that none have been validated casting doubts on their accuracy and clinical utility. We propose a prospective study to compare the effectiveness of FSI vs. diameter-based approaches in predicting true wall stress in surgical aTAA patients. Aims are: 1) Develop and validate in vivo patient-specific FSI in aTAA patients undergoing repair with the gold standard, ex vivo patient-specific aTAA from surgical specimen controls; 2) Demonstrate superiority of in vivo FSI over diameter in predicting true wall stress; 3 Quantify aTAA wall material strength from aTAA specimens and elucidate its relationship to regional aTAA wall stress. Develop empirical model to noninvasively predict in vivo wall strength; 4) Compare aortic wall stress and material properties between normal subjects and surgical aTAA patients. Define high-risk profiles using wall stress, fluid shear stress and turbulence, and clinical risk factors. We propose to first improve accuracy of in vivo aTAA FSI using 4-D flow cardiac magnetic resonance imaging (CMR) with Cine Displacement Encoding with Simulated Echos (DENSE) to determine wall material properties, wall thickness, and zero-stress geometry. We will validate in vivo models with surgical aTAA specimens and correlate aTAA failure strength with stress. Our development of high risk profiles using advanced CMR techniques to determine wall stress and fluid shear stress coupled with clinical risk factors may be used in the future to prospectively follow and predict growth and complications in all aTAA patients
描述(由申请人提供):升胸主动脉瘤 (aTAA) 的夹层和/或破裂是灾难性的紧急情况,院前死亡率为 40%,手术死亡率高达 25%。临床指南建议主要基于 aTAA 进行择期手术修复。然而,A 型夹层患者的比例相当大。我们的长期目标是利用患者特定的生物力学、流体动力学和临床特征来实现 aTAA 临床决策的现代化,以预测破裂/夹层并对患者进行风险分层,以便进行早期手术修复。是,aTA 破裂/剥离是当壁应力超过壁强度时发生的机械故障。根据拉普拉斯定律,指南使用直径作为壁应力的替代。我们捕获了流体结构相互作用。不幸的是,aTAA 壁应力的 (FSI) 分析可以更好地预测真实壁应力,因此比直径更好地预测不良临床事件。真实壁应力无法在体内直接测量,而是需要离体 aTAA 样本,其中患者特定的 3D 样本。零压力几何形状、壁厚、残余应力和材料属性可以以非常高的分辨率进行测量,之前的 aTAA 计算模型使用广义壁厚、基于文献的材料属性做出了许多假设,并且经常忽略零应力几何形状。其中实质性改变模拟迄今为止,aTAA 模型的致命弱点是尚未对其准确性和临床实用性产生怀疑,我们提出了一项前瞻性研究来比较 FSI 与基于直径的方法在预测手术 aTAA 中真实壁应力方面的有效性。目标是: 1) 在接受手术标本对照的金标准、离体患者特异性 aTAA 修复的 aTAA 患者中开发和验证体内患者特异性 FSI;2) 证明体内方法的优越性;通过 FSI 预测真实的壁应力;3 量化 aTAA 样本的 aTAA 壁材料强度,并阐明其与局部 aTAA 壁应力的关系;开发经验模型以无创地预测体内壁强度;4) 比较正常情况下的主动脉壁应力和材料特性。我们建议首先提高体内 aTAA 的准确性。 FSI 使用 4-D 血流心脏磁共振成像 (CMR) 和模拟回波电影位移编码 (DENSE) 来确定壁材料特性、壁厚度和零应力几何形状。我们将使用手术 aTAA 标本验证体内模型并进行关联。 aTAA 应力失效强度。我们使用先进的 CMR 技术开发高风险概况,以确定壁应力和流体剪切应力以及临床风险因素,将来可用于前瞻性跟踪和预测所有疾病的生长和并发症。 aTAA 患者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liang Ge其他文献
Liang Ge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liang Ge', 18)}}的其他基金
Biomechanical Understanding of Ascending Thoracic Aortic Aneurysms
胸主动脉瘤的生物力学理解
- 批准号:
9043944 - 财政年份:2015
- 资助金额:
$ 38.33万 - 项目类别:
Functional Dissection of Autophagosome Biogenesis
自噬体生物发生的功能剖析
- 批准号:
8868838 - 财政年份:2015
- 资助金额:
$ 38.33万 - 项目类别:
相似国自然基金
肠道神经氨酸酶-3在主动脉瘤中的作用及机制研究
- 批准号:82300544
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
巨噬细胞参与腹主动脉瘤发生的关键基因鉴定及Trem2在腹主动脉瘤中的作用研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
流体剪切力在胸主动脉瘤向胸主动脉夹层演变中的作用及机制研究
- 批准号:12372315
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
腹主动脉瘤患者肠道噬菌体组异常及其病因学作用和机制的研究
- 批准号:82370481
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
核因子КB受体活化因子配体在腹主动脉瘤形成中的作用及机制研究
- 批准号:82370486
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Accelerated Cerebrovascular Aging in a Fibrillin-1 Mutated Mouse Model
Fibrillin-1 突变小鼠模型加速脑血管老化
- 批准号:
10727231 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
PCSK9 抑制对腹主动脉瘤病理学和生长的影响
- 批准号:
10566800 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Towards Personalized Prosthetic Graft Replacement for Genetically Triggered Thoracic Aortic Aneurysms
针对基因触发的胸主动脉瘤的个性化假体移植
- 批准号:
10753115 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Complementary animal and computational models for biomarker identification in ascending thoracic aortic aneurysm
升主动脉瘤生物标志物识别的补充动物和计算模型
- 批准号:
10503513 - 财政年份:2022
- 资助金额:
$ 38.33万 - 项目类别: